VIM-producing CRPA among Adult Patients Who Underwent Bariatric Surgery In Mexico
Indiana Health Alert Network Advisory — March 13, 2019
VERONA INTEGRON-MEDIATED METALLO-ß-LACTAMASE (VIM)-PRODUCING CARBAPENEM-RESISTANT Pseudomonas aeruginosa (CRPA) AMONG ADULTS WHO UNDERWENT BARIATRIC SURGERY IN MEXICO
Several state health departments and the Centers for Disease Control and Prevention (CDC) are investigating 16 infections of Verona Integron-mediated Metallo-ß-lactamase (VIM)-producing carbapenem-resistant Pseudomonas aeruginosa (CRPA) among adult patients who underwent bariatric surgery in Mexico between August 21, 2018 to January 15, 2019. Of those infected, eight surgical site infections and one bloodstream infection have been identified. Twelve of the 16 patients for whom additional information was available reported receiving gastric sleeve surgery at Grand View Hospital in Tijuana, Mexico.
Health care providers should report any cases of Pseudomonas aeruginosa infections in patients who report a history of bariatric surgery in Tijuana, Mexico since August 1, 2018 to DJ Shannon, ISDH Antimicrobial Resistance Epidemiologist, at email@example.com or 317-233-1306.